Reassessing cytomegalovirus as a relevant transfusion-transmitted infection - 17/10/26
Doi : 10.1016/j.tracli.2026.09.007
Jeremy W. Jacobs a, Steven J. Drews b, c, d, Evan M. Bloch e, ⁎ 
a Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, TN, United States
b Surveillance and Discovery Laboratory, Canadian Blood Services, Ottawa, Ontario, Canada
c Medical Microbiology, Canadian Blood Services, Edmonton, Alberta, Canada
d Division of Diagnostic and Applied Microbiology, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada
e Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University School of Medicine, 600N. Wolfe Street/Carnegie 446 D1, Baltimore, MD, 21287, United States
⁎ Corresponding author.
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Saturday 17 October 2026
Highlights |
• | Studies of transfusion-transmitted CMV rarely exclude competing sources of infection. |
• | Donor-recipient molecular linkage of CMV rests on a single 1985 case series. |
• | Countries without routine leukoreduction report no molecularly confirmed cases. |
• | Whole-genome sequencing should be used to establish or refute donor-recipient linkage. |
Plan
© 2026
Société francophone de transfusion sanguine (SFTS). Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?